Article info

Download PDFPDF
Original research
Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

Authors

  1. Correspondence to Dr Aamir Khakwani, Division of Epidemiology & Public Health, University of Nottingham, Nottingham, UK; Aamir.Khakwani{at}nottingham.ac.uk
View Full Text

Citation

Khakwani A, Harden S, Beckett P, et al
Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

Publication history

  • Received August 15, 2018
  • Revised October 4, 2019
  • Accepted October 9, 2019
  • First published December 26, 2019.
Online issue publication 
March 04, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.